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In 1988, the International Agency for Research on Cancer (IARC)
Monograph on the carcinogenic risk to humans of alcohol
drinking concluded that the occurrence of malignant tumours of
the oral cavity, pharynx, larynx, oesophagus and liver was causally
related to the consumption of alcoholic beverages. In an updated
review (Baan et al, 2007; Secretan et al, 2009), they noted the
consistent finding of an increased risk of breast cancer with
increasing alcohol intake, and that an association between alcohol
consumption and colorectal cancer had been reported by more
than 50 prospective and case–control studies, with no difference
in the risk for colon and rectal cancers (Baan et al, 2007). The
World Cancer Research Fund report (WCRF, 2007) considered that
the evidence for an association of alcohol intake with these sites
was convincing and, for liver cancer, probable.
METHODS
Quantitative risk of alcohol
Table 1 shows the increase in risk associated with consumption of
1g per day of alcohol. The estimates in these studies had been
adjusted for major confounders, notably smoking.
With respect to breast cancer, the estimate was derived from a
meta-analysis of 53 studies, conducted by the Collaborative Group
on Hormonal Factors in Breast Cancer (Hamajima et al, 2002),
which found that the risk was increased by 7.1% for every 10g of
daily alcoholintake. The values observed in subsequent studies are
not substantially different. A pooled analysis of six cohort studies
with data on alcohol and dietary factors found that the risk of
breast cancer increased monotonically with increasing intake of
alcohol; the multivariate relative risk (RR) for a 10-g per day
increase in alcohol was 1.09 (95% CI¼1.04–1.13; Smith-Warner
et al, 1998). The EPIC study (Tjønneland et al, 2007) found that the
risk was 1.03 (95% CI¼1.01–1.05) per 10-g per day recent alcohol
intake, whereas in the Million Women Study the increase in risk
associated with 10g per day intake was 12% (Allen et al, 2009).
With respect to cancers of the colorectum, a pooled analysis of
eight cohort studies reported a borderline statistically significant
16% risk increase for people drinking 30–45g per day of alcohol
and a significant 41% risk increase for people drinking X45g per
day (Cho et al, 2004). A more recent meta-analysis of cohort
studies found a 15% increase in the risk of colon or rectal cancer
for an increase of 100g alcohol intake per week (Moskal et al,
2007), with no difference between men and women. In the EPIC
study (Ferrari et al, 2007), the effect was a bit weaker, with alcohol
intake at study baseline increasing colorectal cancer risk by 9% per
15g per day, a risk greater for rectal cancer than for cancer of the
distal colon, which in turn was greater than the risk for cancer of
the proximal colon. In the WCRF (2007) report, a meta-analysis
of eight studies of colon cancer yielded a combined RR of 1.09
(1.03–1.14) per 10g intake per day, and a meta-analysis of nine
studies of rectal cancer yielded an RR of 1.06 (1.01–1.12) per 10g
intake per day.
The means in the meta-analyses of Cho et al (2004), Moskal et al
(2007), the EPIC study (Ferrari et al, 2007) and WCRF (2007) are
0.75% per gram alcohol per day for colon cancer and 0.85% per
gram per day for rectal cancer. As these estimates are similar, the
global figure of 0.8% per gram (increase of 0.008 per gram per day)
was used for colorectal cancer as a whole (Table 1).
For the remaining cancers, the meta-analysis of Corrao et al
(2004) was used to estimate the RRs. They present RRs associated
with a mean intake of 0, 25, 50 and 100g of alcohol per day. The
RR per gram of alcohol intake was estimated by assuming a log–
linear relationship between exposure and risk, so that:
RelativeriskðxÞ¼expðlnðriskperunitÞ exposurelevelðxÞÞ
where x is the exposure level (in grams per day).
Prevalence of exposure to alcohol
The latent period or interval between ‘exposure’ to alcohol and the
appropriate increase in risk of these cancers is not known. We
chose to assume that this would be, on average, 10 years, and thus
examine the effects on cancers occurring in 2010 from non-optimal
levels of alcohol consumption in the year 2000.
There are two main ways of measuring the amount of alcohol
consumed: asking people how much alcohol they drink or
counting how much alcohol is sold. As the estimates of the effect
of past alcohol drinking on cancer risk are based on epidemio-
logical studies in which alcohol intake is estimated from
questionnaire data, it is most appropriate to base the exposure
prevalence on data from a similar source.
We have used data from the National Diet and Nutrition Survey,
a survey of the diet and nutrition of a representative sample of
adults in the age group of 19–64 years living in private households
in Great Britain, carried out between July 2000 and June 2001 *Correspondence: Professor DM Parkin; E-mail: d.m.parkin@qmul.ac.uk
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www.bjcancer.com(Henderson et al, 2003). For the age group 465 years, we used
data on the proportion of non-drinkers, and average alcohol
consumption from the General Household Survey (for England)
(Goddard, 2006). From these tables, an estimate was prepared of
the proportions of individuals (by age group and sex) consuming
different quantities of alcohol in terms of grams per day, assuming
that 1 unit of alcoholic beverages contains 8g of pure alcohol
(Table 2).
The same data are shown in Figure 1, as the cumulative
percentages of men and women of different ages with different
levels of alcohol intake in 2000, as grams per day of alcohol.
Estimation of population attributable fractions (PAFs)
For the six cancer types, PAFs were calculated for each sex–age
group according to the usual formula:
PAF ¼
Sðpx ERRxÞ
1 þ Sðpx ERRxÞ
where px is the proportion of the population in consumption level
x (x¼1–12) and ERRx the excess relative risk (RRx 1) in con-
sumption level x (x¼1–12).
The ERR of alcohol consumption for each level x of alcohol
consumption given in Table 2 was calculated as follows:
ERRx ¼ expðRg GxÞ 1
where Rg is the increase in risk per gram of alcohol intake (Table 1)
and Gx the intake of alcohol (grams per day) in consumption
category x (Table 2).
RESULTS
T a b l e3s h o w sf o re a c hs e xa n da g eg r o u pt h en u m b e r so fc a s e so ft h e
six alcohol-related cancers in the UK in 2010, the PAFs due to alcohol
consumption 10 years earlier (2000–2001) and the corresponding
number of excess cases (calculated as (observed PAF)).
Because of the high risk of upper aero-digestive tract cancer
associated with alcohol drinking, cancers of the mouth and
pharynx, as well as larynx, had the highest percentages of alcohol-
attributable cases (30.4% of cancers of the oral cavity and pharynx,
24.6% of laryngeal cancers). Although the fractions of colorectal
(11.6%) and breast (6.4%) cancers were much lower, the actual
numbers of alcohol-attributable cases were much greater –
together, they account for about 7700 alcohol-attributable cases
in 2010 (or 62% of all alcohol-related cancers).
Table 4 sums the excess numbers of cases at the six sites, caused
by alcohol consumption, and expresses these numbers as a fraction
of the total burden of (incident) cancer. The estimates are 4.6%
Table 2 Estimated percentage of the population at 12 levels of alcohol consumption
% of population consuming the specified grams per day alcohol in Great Britain during 2000–2001
Alcohol consumption Men by age (years) Women by age (years)
Level Grams per day 19–24 25–34 35–49 50–64 65+ All 19+ 19–24 25–34 35–49 50–64 65+ All 19+
1 0 20 18 16 23 26 20 29 31 31 33 49 35
2 0 . 5 2112 4 20235 3 3
3 1 . 5 3414 5 38655 4 5
4 3.5 5 8 11 7 7 8 11 10 10 15 9 11
5 7.5 16 9 10 8 11 10 16 16 18 9 8 13
6 12.5 14 8 6 14 10 10 7 12 11 9 7 9
7 17.5 4 14 9 7 8 9 7 10 7 7 6 7
8 2 5 1 11 11 6 97 1 11 0 7 91 179
9 3 5 57 1 15 6 75533 4 4
1 0 4 5 7558 5 64023 2 2
1 1 5 5 8453 6 52000 1 0
1 2 7 0 5 1 19 1 0 5 81110 0 0
Mean grams per day 20.4 22.2 23.1 21.1 12.6 23.6 11.4 9.1 9.2 8.6 7.7 11.6
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Figure 1 Cumulative percentage of population with different alcohol
intakes.
Table 1 Increase in risk of cancer associated with 1 gram of alcohol per
day
Cancer type Studies
Increase in risk per gram
alcohol per day
Oral cavity and pharynx Corrao et al (2004) 0.0185
Larynx Corrao et al (2004) 0.0136
Oesophagus Corrao et al (2004) 0.0129
Colorectal cancer Cho et al (2004) 0.0080
Moskal et al (2007)
Ferrari et al (2007)
WCRF (2007)
Breast Collaborative Group
(Hamajima et al, 2002)
0.0071
Liver Corrao et al (2004) 0.0059
Alcohol
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or 4.0% cancers overall.
DISCUSSION
The estimates of the RR of alcohol consumption for various
cancers are an ‘average’ taken from widely cited meta-analyses;
more extreme values can be found in specific studies.
Table 5 compares the excess RRs of 1g of alcohol consumption
per day as used in this study with those from the Million Women
Study (Allen et al, 2009) and the EPIC study (Ferrari et al, 2007;
Tjonneland et al, 2007), as well as with those derived from various
meta-analyses by WCRF (2007). The values for cohort studies are
shown for cancers of the breast, colon, rectum and liver. For upper
aero-digestive and oesophageal cancers, meta-analyses were based
on case–control studies only.
For the most part, the risks associated with consumption of
alcohol used in the present study are similar to those in the three
comparative studies listed in Table 5. The ERRs reported in the
Million Women Study (Allen et al, 2009) are rather higher than
those in Table 1 for cancers of the oesophagus, liver and larynx,
although the values used in the current analysis (Table 1) lie within
the relevant 95% confidence intervals; for colon cancer, however,
the value is considerably lower.
With respect to cancer of the oesophagus, some of the
differences may relate to the differing proportions of squamous
cell and adenocarcinomas in the series of cancers in various
studies. Although squamous cell carcinomas are clearly related to
alcohol exposure, the risk of adenocarcinoma is much lower, or nil
(Lagergren et al, 2000; Wu et al, 2001; Lindblad et al, 2005;
Pandeya et al, 2009). Currently, adenocarcinomas comprise
Table 3 Cancer cases diagnosed in 2010 attributable to alcohol consumption in 2000–2001





























15–24 25–34 0.36 55 19.6 0.25 11 2.8 0.16 133 20.8 0.12 19 2.1 0.26 2 0.5
25–34 35–44 0.39 244 96.1 0.28 86 24.0 0.17 397 69.2 0.13 43 5.5 0.29 35 10.3
35–49 45–59 0.40 1591 631.8 0.28 970 274.9 0.18 2921 521.1 0.13 351 46.4 0.30 407 121.3
50–64 60–74 0.38 1888 709.1 0.26 2535 668.2 0.16 9481 1548.0 0.12 1011 121.4 0.28 914 253.9
X65 X75 0.32 768 249.1 0.22 2108 473.7 0.14 9162 1262.7 0.10 828 83.7 0.24 444 105.3
Total 4571 1705.9 5713 1443.5 22127 3421.8 2270 259.1 1803 491.3
% 37.3 25.3 15.5 11.4 27.3
Women
15–24 25–34 0.23 50 11.4 0.16 4 0.6 0.10 136 13.0 0.07 12.11 0.9 0.17 2 0.3 0.08 715.1 60.7
25–34 35–44 0.18 131 23.2 0.12 27 3.3 0.07 402 29.9 0.05 29.48 1.6 0.13 12 1.5 0.07 3857 254.0
35–49 45–59 0.18 622 113.5 0.12 303 37.9 0.08 2292 174.8 0.06 142.8 8.0 0.13 99 13.1 0.07 14628 987.4
50–64 60–74 0.17 855 146.3 0.12 922 108.5 0.07 6116 440.7 0.05 453 23.9 0.12 168 20.9 0.06 17194 1096.9
X65 X75 0.16 666 105.2 0.11 1560 166.8 0.06 8810 568.8 0.05 642.4 30.2 0.11 101 11.4 0.06 11952 681.3
Total 2359 399.7 2819 317.2 17787 1227.3 1298 64.6 386 47.3 48385 3080.3
% 16.9 11.3 6.9 5.0 12.2 6.4
Persons
15–24 25–34 105 31.1 15 3.4 269 33.8 31 3.0 4 0.9 715 60.7
25–34 35–44 375 119.3 113 27.3 799 99.1 72 7.1 47 11.8 3857 254.0
35–49 45–59 2213 745.4 1273 312.8 5213 695.9 494 54.3 506 134.4 14628 987.4
50–64 60–74 2743 855.5 3457 776.7 15597 1988.8 1464 145.4 1082 274.8 17194 1096.9
X65 X75 1434 354.3 3668 640.5 17972 1831.5 1470 113.9 545 116.7 11952 681.3
Total 6930 2105.6 8532 1761 39914 4649 3568 324 2189 539 48385 3080
% 30.4 20.6 11.6 9.1 24.6 6.4
Abbreviations: attrib.¼attributable; Obs.¼observed cases; PAF¼population-attributable fraction.
Table 4 Estimated total numbers of cancers in the UK in 2010, PAFs due
to alcohol consumption 10 years earlier (2000–2001), and the corresponding
number and percentage of excess cases, by age group and sex












15–24 25–34 2109 46 2.2
25–34 35–44 4124 205 5.0
35–49 45–59 22388 1596 7.1
50–64 60–74 68043 3301 4.9
X65 75+ 60149 2175 3.6
Total 158667 7322 4.6
Women
15–24 25–34 3284.1 87 2.6
25–34 35–44 8619.2 313 3.6
35–49 45–59 31631 1335 4.2
50–64 60–74 54966 1837 3.3
X65 75+ 55437 1564 2.8
Total 155584 5136 3.3
Persons
15–24 25–34 5393 133 2.5
25–34 35–44 12743 519 4.1
35–49 45–59 54019 2930 5.4
50–64 60–74 123009 5138 4.2
X65 75+ 115586 3738 3.2
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40% in women (see section 8, in Cancers attributable to overweight
and obesity). However, the studies currently used to estimate the
RR of oesophageal cancer in relation to alcohol do not distinguish
between the histological subtypes, and no correction to the
estimate for the UK has been made on this basis.
We chose to use the estimates of alcohol consumption in the UK
based on population survey data (the National Diet and Nutrition
Survey). However, it is well known that surveys produce figures far
lower than would be expected from alcohol sales. Alcohol sales are
estimated based on clearance data produced by HM Revenue and
Customs (HMRC). Not all alcohol that is cleared is actually
consumed; for example, it is conceivable that some of it may be
thrown away when it passes its best-before date. Conversely, not all
alcohol that is consumed in the UK is cleared by HMRC; for
example, home brew and illegally imported alcohol.
Table 6 compares consumption as estimated by the General
Household Survey (Goddard, 2006) and from clearance data
produced by HM Revenue and Customs (HMRC, 2008). The large
difference between the two sets of data is unlikely to be due to large
amounts of purchased alcohol not being consumed. Both the
General Household Survey and the Government’s alcohol strategy
(HMG, 2007) believe that many people underestimate the amount of
alcohol they drink. However, as estimates of risk are generally based
on responses to questionnaires, they are likely to overestimate the
risk in relation to actual alcohol consumption. It is more appro-
priate, therefore, to use estimates of alcohol intake from (self-
reported) survey data than the more accurate clearance data.
The current estimate (3.6% of new cancers in 2010 related
to alcohol) is similar to the figure published by Doll and Peto
(2003) – that around 6% of UK cancer deaths could be avoided
if people did not drink. The estimation is based on the attribution
to alcohol of 2/3 deaths from alcohol-related cancers (mouth,
pharynx, larynx, oesophagus) in men and 1/3 in women,
plus ‘a small proportion’ of liver cancer deaths. A recent
publication, based on the risks of alcohol consumption observed
in the EPIC study, estimates a rather higher fraction of cancers
attributable to alcohol in the UK – especially in men: 8% of cancer
in men and 3% in women (Schu ¨tze et al, 2011). The difference
appears to be mainly because of the rather higher level and
prevalence of alcohol consumption that were used to estimate
attributable fractions (an average intake of 35.2g per day in men
and 17.6g per day in women, cf. Table 2). These were calculated
from data available on the World Health Organisation website,
which appear to be derived from clearance data, with levels of
consumption equivalent to those in Table 6 (on average, annually
13.4l of alcohol per capita in 2003–5). As noted above, it would
seem more appropriate to use self-reported consumption, even
though this is an underestimate of the true situation, as the RR
estimates in EPIC (as in other cohort studies) are also based on
questionnaire data.
See acknowledgements on page Si.
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aMillion Women Study, Allen et al (2009).
bWCRF (2007).
cEuropean Prospective
Investigation into Cancer and Nutrition, Ferrari et al (2007).
dTjonneland et al (2007).
eBased on meta-analysis of case–control studies only.
Table 6 UK alcohol consumption per adult
General Household Survey
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aGeneral Household Survey (Goddard, 2006).
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